title: Expression of angiopoietin-TIE system components in angiosarcoma.
abstract: Angiosarcoma is an aggressive malignancy of endothelial differentiation. Potential roles of the endothelial angiopoietin-tunica interna endothelial cell kinase (ANGPT-TIE) system in angiosarcoma diagnosis, pathogenesis, prognosis and treatment are undefined. To examine the expression and prognostic significance of angiopoietin-1, angiopoietin-2, TIE1 and TEK (TIE2) proteins in angiosarcoma, we immunohistochemically evaluated clinically annotated human angiosarcoma samples. Correlations of protein expression with overall survival and pathological features were explored. The cohort included 51 patients diagnosed with angiosarcoma at the age of 30-86 years (median 67). The 5-year overall survival was 45% with a median of 26 months. Moderate to strong expression of angiopoietin-1, TIE1 and TEK (TIE2) was identified in the majority of angiosarcomas and moderate to strong expression of angiopoietin-2 was observed in 42% of angiosarcomas. Increased angiopoietin-1 expression correlated with improved survival. Non-significant trends toward longer survival were also observed with increased TIE1 and TEK (TIE2) expression. Increased expression of angiopoietin-2, TIE1 and TEK (TIE2) was associated with vasoformative architecture. No differences in expression of these proteins were observed when patients were segregated by age, gender, presence or absence of metastases at diagnosis, primary tumor location, radiation association or the presence of necrosis. We conclude that components of the ANGPT-TIE system are commonly expressed in angiosarcomas. Reduced expression of these proteins is associated with non-vasoformative and clinically more aggressive lesions.
authors.affiliation: Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
authors.forename: Darya
authors.initials: D
authors.lastname: Buehler
authors.forename: Patrick
authors.initials: P
authors.lastname: Rush
authors.forename: Jason R
authors.initials: JR
authors.lastname: Hasenstein
authors.forename: Stephanie R
authors.initials: SR
authors.lastname: Rice
authors.forename: Gholam Reza
authors.initials: GR
authors.lastname: Hafez
authors.forename: B Jack
authors.initials: BJ
authors.lastname: Longley
authors.forename: Kevin R
authors.initials: KR
authors.lastname: Kozak
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D042682:Angiopoietins / Q000032:analysis / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D006394:Hemangiosarcoma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D042764:Receptors, TIE / Q000032:analysis / Q000096:biosynthesis*; D012983:Soft Tissue Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D046888:Tissue Array Analysis
chemical_list: D042682:Angiopoietins; D014408:Biomarkers, Tumor; D042764:Receptors, TIE
references.citation: J Cutan Pathol. 2011 Dec;38(12):961-6
references.pmid: 22050093
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1904-9
references.pmid: 10051567
references.citation: Cancer Res. 2009 Sep 15;69(18):7175-9
references.pmid: 19723655
references.citation: Science. 1997 Jul 4;277(5322):55-60
references.pmid: 9204896
references.citation: Cancer Res. 2002 Dec 1;62(23):7124-9
references.pmid: 12460935
references.citation: J Clin Oncol. 2009 Jul 1;27(19):3133-40
references.pmid: 19451436
references.citation: Cancer J. 2005 May-Jun;11(3):241-7
references.pmid: 16053668
references.citation: Ann Surg. 2010 Jun;251(6):1098-106
references.pmid: 20485141
references.citation: Nat Cell Biol. 2008 May;10(5):513-26
references.pmid: 18425120
references.citation: Hum Pathol. 2010 Mar;41(3):407-14
references.pmid: 19913279
references.citation: EMBO J. 1995 Dec 1;14(23):5884-91
references.pmid: 8846781
references.citation: J Surg Oncol. 2008 Jan 1;97(1):74-81
references.pmid: 18041747
references.citation: Lung Cancer. 2000 Jul;29(1):11-22
references.pmid: 10880843
references.citation: Cancer. 1995 Jun 15;75(12):2867-74
references.pmid: 7773935
references.citation: Hepatology. 2003 May;37(5):1105-13
references.pmid: 12717391
references.citation: Curr Oncol Rep. 2009 Mar;11(2):111-6
references.pmid: 19216842
references.citation: Lab Invest. 1995 Dec;73(6):859-63
references.pmid: 8558848
references.citation: Cell. 1996 Dec 27;87(7):1171-80
references.pmid: 8980224
references.citation: Cancer. 2012 Dec 15;118(24):6152-61
references.pmid: 22692704
references.citation: Circ Res. 2000 Jan 7-21;86(1):24-9
references.pmid: 10625301
references.citation: J Clin Oncol. 2012 Feb 1;30(4):362-71
references.pmid: 22184370
references.citation: Neoplasia. 2012 Feb;14(2):131-40
references.pmid: 22431921
references.citation: Am J Pathol. 1996 Apr;148(4):1065-74
references.pmid: 8644848
references.citation: Nature. 1995 Jul 6;376(6535):70-4
references.pmid: 7596437
references.citation: Gynecol Oncol. 2004 Apr;93(1):215-22
references.pmid: 15047239
references.citation: Ann Surg Oncol. 2007 Jun;14(6):1953-67
references.pmid: 17356953
references.citation: Oncologist. 2012;17(2):260-6
references.pmid: 22285963
references.citation: Genes Dev. 1994 Aug 15;8(16):1897-909
references.pmid: 7958865
references.citation: J Surg Oncol. 1996 Mar;61(3):170-6
references.pmid: 8637202
references.citation: Br J Dermatol. 2010 Jul;163(1):225-7
references.pmid: 20394623
references.citation: Br J Dermatol. 2010 Nov;163(5):920-7
references.pmid: 20633009
references.citation: Am J Pathol. 1998 Nov;153(5):1425-33
references.pmid: 9811333
references.citation: Br J Dermatol. 2004 May;150(5):1028-9
references.pmid: 15149523
references.citation: Int J Cancer. 2003 Feb 10;103(4):466-74
references.pmid: 12478661
references.citation: Crit Rev Oncol Hematol. 2011 Nov;80(2):257-63
references.pmid: 21055965
references.citation: Endocr Relat Cancer. 2009 Sep;16(3):967-76
references.pmid: 19502452
references.citation: Lung Cancer. 2009 Jul;65(1):49-55
references.pmid: 19100646
references.citation: Clin Cancer Res. 2010 Jun 1;16(11):3044-56
references.pmid: 20501621
references.citation: Am J Pathol. 2000 Jun;156(6):2179-83
references.pmid: 10854238
references.citation: Nat Cell Biol. 2008 May;10(5):527-37
references.pmid: 18425119
references.citation: Cancer. 1996 Jun 1;77(11):2400-6
references.pmid: 8635113
references.citation: Cancer Res. 2001 Feb 15;61(4):1255-9
references.pmid: 11245414
references.citation: Ann Oncol. 2013 Jan;24(1):257-63
references.pmid: 22910841
references.citation: FASEB J. 2011 Oct;25(10):3325-35
references.pmid: 21685330
references.citation: Ann Oncol. 2007 Dec;18(12):2030-6
references.pmid: 17974557
references.citation: Dev Cell. 2002 Sep;3(3):411-23
references.pmid: 12361603
references.citation: Nat Rev Cancer. 2010 Aug;10(8):575-85
references.pmid: 20651738
references.citation: Cell. 1996 Dec 27;87(7):1161-9
references.pmid: 8980223
references.citation: BJU Int. 2005 Mar;95(4):660-3
references.pmid: 15705099
references.citation: Cancer Res. 2005 Aug 1;65(15):6820-7
references.pmid: 16061664
references.citation: Prostate. 2005 Mar 1;62(4):394-9
references.pmid: 15378518
references.citation: J Clin Oncol. 2009 Jul 20;27(21):3557-65
references.pmid: 19546406
references.citation: Exp Mol Med. 2009 Mar 31;41(3):133-9
references.pmid: 19293632
references.citation: J Surg Oncol. 2006 Dec 1;94(7):631-8
references.pmid: 17066421